Advertisement

Journal of General Internal Medicine

, Volume 35, Issue 1, pp 51–56 | Cite as

De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers’ Perspectives

  • Krysttel Stryczek
  • Colby Lea
  • Chris Gillespie
  • George Sayre
  • Scott Wanner
  • Seppo T. Rinne
  • Renda Soylemez Wiener
  • Laura Feemster
  • Edmunds Udris
  • David H. Au
  • Christian D. HelfrichEmail author
Original Research

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is among the most common medical diagnoses among Veterans. More than 50% of Veterans diagnosed with mild-to-moderate COPD are prescribed inhaled corticosteroids despite recommendations for use restricted to patients with frequent exacerbations.

Objective

We explored primary care providers’ experiences prescribing inhaled corticosteroids among patients with mild-to-moderate COPD as part of a quality improvement initiative.

Design

We used a sequential mixed-methods evaluation approach to understand factors influencing primary care providers’ inhaled corticosteroid prescribing for patients with mild-to-moderate COPD. Participants were recruited to participate in qualitative interviews and structured surveys.

Participants

We used a purposive sample of primary care providers from 13 primary care clinics affiliated with two urban Veteran Health Administration healthcare systems.

Main Measures

Interviews were transcribed and analyzed using content analysis. Qualitative findings informed a subsequent survey. Surveys were administered through REDCap and analyzed descriptively. Key qualitative and quantitative findings were compared.

Key Results

Participants reported they were unaware of current evidence and recommendations for prescribing inhaled corticosteroids; for example, 46% of providers reported they were unaware of risks of pneumonia. Providers reported they are generally unable to keep up with the current literature due to the broad scope of primary care practice. We also found primary care providers may be reluctant to change inherited prescriptions, even if they thought inhaled corticosteroid therapy might not be appropriate.

Conclusions

Inhaled corticosteroid prescribing in this patient population is partly due to primary care providers’ lack of knowledge about the potential harms and availability of alternative therapies. Our findings suggest that efforts to expand access by increasing the number of prescribing providers a patient potentially sees could make it more difficult to de-implement harmful prescriptions. Our findings also corroborate prior findings that awareness of current evidence-based guidelines is likely an important part of medical overuse.

KEY WORDS

de-implementation quality improvement mixed methods de-prescribing COPD 

Notes

Acknowledgments

We are thankful to our project manager, Barbara Majerczyk, MPH, for her contributions that made this work possible. This work was supported by the United States Department of Veterans Affairs VA Quality Enhancement Research Initiative (QUERI) QUE 15-271 as part of VHA Health Care Operations in accordance with VHA Handbooks 1605.1 and 1605.2. We have previously presented a portion of these data as posters or oral presentations at the AcademyHealth Annual Conference on the Science of Dissemination & Implementation annual meetings (Washington, D.C., 2016, 2017, and 2018), the AcademyHealth Annual Research Meeting (New Orleans, LA, 2017), the Health Services Research & Development/Quality Enhancement Research Initiative National Conference (Washington, D.C., 2017), and 4th Biennial Society for Implementation Research Collaboration (Seattle, WA, 2017).

Compliance with Ethical Standards

Conflict of Interest

Dr. Feemster receives funding from NIH K23 HL111116. Dr. Au receives remuneration from Novartis Inc. for participation on a data safety monitoring board. He serves as a Deputy Editor for the Annals of the American Thoracic Society and is a member of the Exam Committee for the American Board of Internal Medicine Pulmonary Board, for which he receives remuneration. The remaining authors declare that they have no conflict of interest.

Disclaimer

The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States Government.

Supplementary material

11606_2019_5193_MOESM1_ESM.docx (24 kb)
ESM 1 (DOCX 24 kb)

References

  1. 1.
    Global Initiative for Chronic Obstructive Lung Disease (GOLD). GOLD 2017 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2017 report. November 17, 2016.Google Scholar
  2. 2.
    Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, … Calverley PM, WISDOM Investigators. Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med. 2014;371:1285–1294.CrossRefGoogle Scholar
  3. 3.
    Singh S, Amin AV, Loke YK. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med. 2009;169:219–229.CrossRefGoogle Scholar
  4. 4.
    Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, ... Vogelmeier CF. Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD. N Engl J Med. 2016;374:2222–2234.CrossRefGoogle Scholar
  5. 5.
    Collins BF, Ramenofsky D, Au DH, Ma J, Uman JE, Feemster LC. The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest. 2014;146:1513–1520.CrossRefGoogle Scholar
  6. 6.
    Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3:CD010115.Google Scholar
  7. 7.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW… Vestbo J, TORCH Investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–789.CrossRefGoogle Scholar
  8. 8.
    Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA, INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008;177:19–26.CrossRefGoogle Scholar
  9. 9.
    Coombs C, Hislop D, Holland J, Bosley S, Manful E. Exploring types of individual unlearning by local health-care managers: an original empirical approach. Health Services and Delivery Research. 2013;1.Google Scholar
  10. 10.
    Voorn V, Marang-van de Mheen PJ, So-Osman C, Vlieland TP, Koopman-van Gemert AW, Nelissen RG… van Mourik JB. Designing a strategy to implement cost-effective blood transfusion management in elective hip and knee arthroplasties: a study protocol. Implement Sci. 2012;7:58.CrossRefGoogle Scholar
  11. 11.
    Voorn VM, Marang-van de Mheen PJ, So-Osman C, Kaptein AA, van der Hout A, van den Akker-van Marle ME, … van Bodegom-Vos L. De-implementation of expensive blood saving measures in hip and knee arthroplasties: study protocol for the LISBOA-II cluster randomized trial. Implement Sci. 2014;9:48.CrossRefGoogle Scholar
  12. 12.
    Robert G, Harlock J, Williams I. Disentangling rhetoric and reality: an international Delphi study of factors and processes that facilitate the successful implementation of decisions to decommission healthcare services. Implement Sci. 2014;9:123.CrossRefGoogle Scholar
  13. 13.
    Suissa S, Coulombe J, Ernst P. Discontinuation of inhaled corticosteroids in COPD and the risk reduction of pneumonia. Chest. 2015;148:1177–1183.CrossRefGoogle Scholar
  14. 14.
    Wilkie M, Finch S, Schembri S. Inhaled corticosteroids for chronic obstructive pulmonary disease—the shifting treatment paradigm. COPD. 2015;12:582–590.CrossRefGoogle Scholar
  15. 15.
    Norton WE, Kennedy AE, Chambers DA. Studying de-implementation in health: an analysis of funded research grants. Implement Sci. 2017;12:144.CrossRefGoogle Scholar
  16. 16.
    Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254–1268.CrossRefGoogle Scholar
  17. 17.
    Colla CH, Mainor AJ, Hargreaves C, Sequist T, Morden N. Interventions aimed at reducing use of low-value health services: a systematic review. Med Care Res Rev. 2017;74:507–550.CrossRefGoogle Scholar
  18. 18.
    Keyhani S, Falk R, Howell EA, Bishop T, Korenstein D. Overuse and systems of care: a systematic review. Med Care. 2013;51:503–508.CrossRefGoogle Scholar
  19. 19.
    Morgan DJ, Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L, ... Elshaug AG. Setting a research agenda for medical overuse. BMJ. 2015;351:h4534.CrossRefGoogle Scholar
  20. 20.
    Ailabouni NJ, Nishtala PS, Mangin D, Tordoff JM. Challenges and enablers of deprescribing: a general practitioner perspective. PloS one. 2016;11:e0151066.CrossRefGoogle Scholar
  21. 21.
    Au DH, McDonell MB, Martin DC, Fihn SD. Regional variations in health status. Med Care. 2001;39:879–888.CrossRefGoogle Scholar
  22. 22.
    Fihn SD, McDonell MB, Diehr P, Anderson SM, Bradley KA, Aud DH, … Sauvigne A. Effects of sustained audit/feedback on self-reported health status of primary care patients. Am J Med. 2004;116:241–248.CrossRefGoogle Scholar
  23. 23.
    Quality Enhancement Research Initiative (QUERI). Improving safety and quality through evidence-based de-implementation of ineffective diagnostics and therapeutics (safety & quality QUERI). Available at: https://www.queri.research.va.gov/programs/safety_quality.cfm. Accessed May 8, 2019.
  24. 24.
    Creswell JW, Fetters MD, Ivankova NV. Designing a mixed methods study in primary care. Ann Fam Med. 2004;2:7–12.CrossRefGoogle Scholar
  25. 25.
    Creswell JW & Clark VLP (2017). Designing and conducting mixed methods research. Thousand Oaks: Sage Publications; 2018:221–233.Google Scholar
  26. 26.
    Veterans Health Administration, Department of Veterans Affairs. VHA Handbook 1058.05 VHA operations activities that may constitute research. October 28, 2011.Google Scholar
  27. 27.
    Kitson AL, Rycroft-Malone J, Harvey G, McCormack B, Seers K, Titchen A. Evaluating the successful implementation of evidence into practice using the PARiHS framework: theoretical and practical challenges. Implement Sci. 2008;3:1.CrossRefGoogle Scholar
  28. 28.
    Rycroft-Malone J, Seers K, Titchen A, Harvey G, Kitson A, McCormack B. What counts as evidence in evidence-based practice? J Adv Nurs. 2004;47:81–90.CrossRefGoogle Scholar
  29. 29.
    McCormack B, Kitson A, Harvey G, Rycrosft-Malone J, Titchen A, Seers K. Getting evidence into practice: the meaning of ‘context’. J Adv Nurs. 2002;38:94–104.CrossRefGoogle Scholar
  30. 30.
    Helfrich CD, Rose AJ, Hartmann CW, van Bodegom-Vos L, Graham ID, Wood SJ, … Aron DC. How the dual process model of human cognition can inform efforts to de-implement ineffective and harmful clinical practices: a preliminary model of unlearning and substitution. J Eval Clin Pract. 2018;24:198–205.CrossRefGoogle Scholar
  31. 31.
    Hill CE, Knox S, Thompson BJ, Williams EN, Hess SA, Ladany N. Consensual qualitative research: an update. J Couns Psychol. 2005;52:196–205.CrossRefGoogle Scholar
  32. 32.
    Hill CE, Thompson BJ, Williams EN. A guide to conducting consensual qualitative research. The Counseling Psychologist. 1997;25:517–572.CrossRefGoogle Scholar
  33. 33.
    Elo S & Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62:107–115.CrossRefGoogle Scholar
  34. 34.
    Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.CrossRefGoogle Scholar
  35. 35.
    Maslach C, Jackson SE, Leiter MP. Maslach Burnout Inventory Manual. Third Edition. Menlo Park: Mind Garden; 2010.Google Scholar
  36. 36.
    Bokhof B, Junius-Walker U. Reducing polypharmacy from the perspectives of general practitioners and older patients: a synthesis of qualitative studies. Drugs Aging. 2016;33:249–266.CrossRefGoogle Scholar
  37. 37.
    Luymes CH, van der Kleij RM, Poortvliet RK, de Ruijter W, Reis R, Numans ME. Deprescribing potentially inappropriate preventive cardiovascular medication: barriers and enablers for patients and general practitioners. Ann Pharmacother. 2016;50:446–454.CrossRefGoogle Scholar
  38. 38.
    Voigt K, Gottschall M, Köberlein-Neu J, Schübel J, Quint N, Bergmann A. Why do family doctors prescribe potentially inappropriate medication to elderly patients? BMC Fam Pract. 2016;17:93.CrossRefGoogle Scholar
  39. 39.
    Fairman, J. Making Room in the Clinic: Nurse Practitioners and the Evolution of Modern Health Care. Rutgers University Press, New Brunswick, NJ 2009Google Scholar
  40. 40.
    Rinne ST, Wiener RS, Chen Y, Rise P, Udris E, Feemster LC, Au DH. Impact of guideline changes on indications for inhaled corticosteroids among veterans with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198:1226–1228.CrossRefGoogle Scholar

Copyright information

© Society for General Internal Medicine (This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply) 2019

Authors and Affiliations

  • Krysttel Stryczek
    • 1
    • 2
  • Colby Lea
    • 2
  • Chris Gillespie
    • 3
  • George Sayre
    • 2
    • 4
  • Scott Wanner
    • 5
  • Seppo T. Rinne
    • 3
    • 6
  • Renda Soylemez Wiener
    • 3
    • 6
  • Laura Feemster
    • 2
    • 7
  • Edmunds Udris
    • 2
  • David H. Au
    • 2
    • 7
  • Christian D. Helfrich
    • 2
    • 4
    Email author
  1. 1.VA Northeast Ohio Healthcare SystemClevelandUSA
  2. 2.Seattle-Denver Center of Innovation for Veteran-Centered & Value-Driven Care VA Puget Sound Health Care SystemSeattleUSA
  3. 3.Center for Healthcare Organization & Implementation ResearchEdith Nourse Rogers Memorial VA HospitalBedfordUSA
  4. 4.Department of Health ServicesUniversity of Washington School of Public HealthSeattleUSA
  5. 5.Seattle UniversitySeattleUSA
  6. 6.The Pulmonary CenterBoston University School of MedicineBostonUSA
  7. 7.Division of Pulmonary, Critical Care, and Sleep MedicineUniversity of WashingtonSeattleUSA

Personalised recommendations